title: Cystoid macular edema and macular pigmentation associated with nab-Paclitaxel therapy.
abstract: OBJECTIVE
  To report the first known case of retinal pigment epithelium hyperpigmentation changes and cystoid macular edema in a patient on nab-paclitaxel therapy.
  
  
  METHODS
  Observational case report.
  
  
  RESULTS
  A 72-year-old man on nab-paclitaxel therapy for non-small cell lung carcinoma developed cystoid macular edema with minimal capillary leakage with subsequent retinal pigment epithelium hyperpigmentation after resolution of cystoid macular edema.
  
  
  CONCLUSIONS
  Nab-paclitaxel therapy may be associated with the development of retinal pigment epithelium hyperpigmentation in the setting of resolved minimal capillary leakage cystoid macular edema.
authors.affiliation: *University of California, Irvine School of Medicine, Irvine, California; and †Department of Ophthalmology, Gavin Herbert Eye Institute, Irvine, California.
authors.forename: Asghar
authors.initials: A
authors.lastname: Haider
authors.forename: Simon R
authors.initials: SR
authors.lastname: Bababeygy
authors.forename: Stephanie Y
authors.initials: SY
authors.lastname: Lu
mesh_terms: D000368:Aged; D000418:Albumins / Q000009:adverse effects*; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D008269:Macular Edema / Q000139:chemically induced; D065348:Macular Pigment; D008297:Male; D017239:Paclitaxel / Q000009:adverse effects*; D012164:Retinal Diseases / Q000139:chemically induced*
chemical_list: C520255:130-nm albumin-bound paclitaxel; D000418:Albumins; D000972:Antineoplastic Agents, Phytogenic; D065348:Macular Pigment; D017239:Paclitaxel